MORSE Team

MORSE Team

All the posts published.

Panel 3: Health Technology Assessment   Panel Description: Canada’s centralized HTA agency, CADTH, has recently released a new 3-year strategic plan that … Read More →

Aligned Reviews Between Health Canada (HC) and Health Technology Assessment Organizations (HTAs)   Date: September 26th, 2018 Time: 10:00 AM – 11:30 … Read More →

Panel 2: Pharmacoeconomics   Panel Description: This panel will focus on the growing influence of pharmacoeconomics (PE) in the Canadian reimbursement process. … Read More →

pan-Canadian Pharmaceutical Alliance (pCPA): September 2018 Negotiation Status Update   The pan-Canadian Pharmaceutical Alliance Office (pCPAO) has issued the status of brand … Read More →

Toronto, October 9, 2018 –MORSE Consulting is pleased to announce the addition of Anita Gadhok as Senior Consultant. With more than 20 … Read More →

PMPRB Panel On Tuesday, June 19, 2018, the Canadian Association for Healthcare Reimbursement (CAHR) held the Market Access 201 conference in Toronto. … Read More →

pCPA Biosimilars/Biologics Policy Directions Webinar   On Tuesday September 25, 2018 the pan-Canadian Pharmaceutical Alliance Office (pCPAO) hosted a one-hour webinar for … Read More →

MORSE Consulting has prepared a brief summary of the key highlights from the Patented Medicine Prices Review Board’s (PMPRB) recent webinar on … Read More →

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update   The August 31, 2018 update has been issued by the pan-Canadian Pharmaceutical Alliance. The … Read More →

On September 13th, 2018, the Canadian Agency for Drugs and Technologies in Health (CADTH) issued details on a new CADTH and Institut … Read More →

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update   The July 31, 2018 update has been issued by the pan-Canadian Pharmaceutical Alliance. The … Read More →

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update   The June 30, 2018 update has been issued by the pan-Canadian Pharmaceutical Alliance. The … Read More →

pCPA Brand Process Guidelines Webinar   On Friday, June 22nd, 2018 the pan-Canadian Pharmaceutical Alliance Office (pCPAO) hosted an industry consultation session … Read More →

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update   The May 31, 2018 update has been issued by the pan-Canadian Pharmaceutical Alliance. The … Read More →

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update   The April 30, 2018 update has been issued by the pan-Canadian Pharmaceutical Alliance. The … Read More →

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update   The March 31, 2018 update has been issued by the pan-Canadian Pharmaceutical Alliance Office … Read More →

MORSE Consulting’s Managing Principal, Sherry O’Quinn, and Principal Consultant, Brad Alyward, are proud to participate in this year’s CADTH Symposium taking place … Read More →

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update   The February 28, 2018 update has been issued by the pan-Canadian Pharmaceutical Alliance Office … Read More →

A Comparison of Proposed INESSS and Current CADTH Evaluation Fees   On February 21, 2018, the Quebec government released draft regulations (Gazette … Read More →

pCPA Monthly Trends & Insights – January 2018   The January 31, 2018 update has been issued by the pan-Canadian Pharmaceutical Alliance … Read More →

  Toronto, February 7, 2018: Cornerstone Research Group and MORSE Consulting are pleased to announce the creation of a strategic partnership … Read More →

MORSE Consulting has prepared a Year in Review infographic to highlight some key metrics surrounding the pCPA’s activities in 2017. This analysis … Read More →

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update   The December 31, 2017 update has been issued by the pan-Canadian Pharmaceutical Alliance Office … Read More →

Toronto, January 8, 2018 – Mani & O’Quinn Reimbursement Strategy Experts (MORSE) Consulting is delighted to announce that Brad Alyward has joined our team … Read More →

As we enter the holiday season and the close of MORSE’s first year of operation, we wish to express our heartfelt … Read More →

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update   The November 30, 2017 update has been issued by the pan-Canadian Pharmaceutical Alliance Office … Read More →

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update   The October 31, 2017 update has been issued by the pan-Canadian Pharmaceutical Alliance Office … Read More →

Toronto, October 16, 2017 – Sherry O’Quinn and Arvind Mani are very pleased to announce that Lorraine Boyle has joined the MORSE team … Read More →

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update   The September 30, 2017 update has been issued by the pan-Canadian Pharmaceutical Alliance Office … Read More →

Mani & O’Quinn Reimbursement Strategy Experts (MORSE) Consulting Inc. is pleased to introduce MORSE LINKS, a new feature on our website. MORSE … Read More →

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update   The August 31, 2017 update has been issued by the pan-Canadian Pharmaceutical Alliance Office … Read More →

Toronto, September 11, 2017 – Arvind Mani and Sherry O’Quinn are pleased to announce our newest strategic partner: Stephen Filbey of WestPAR – … Read More →

The MORSE KEY: Upcoming Events and Conferences   There are a number of conferences/events/deadlines that individuals in market access may be interested … Read More →

pCPA Panel   On Tuesday, June 13, 2017, the Canadian Association for Healthcare Reimbursement (CAHR) held the Market Access 201 conference in … Read More →

Quebec Panel   On Tuesday, June 13, 2017, the Canadian Association for Healthcare Reimbursement (CAHR) held the Market Access 201 conference in … Read More →

Health Technology Assessment Panel   On Tuesday, June 13, 2017, the Canadian Association for Healthcare Reimbursement (CAHR) held the Market Access 201 … Read More →

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update   The latest update as of July 31, 2017 has been issued by the pan-Canadian … Read More →

Biosimilar Panel   On Tuesday, June 13, 2017, the Canadian Association for Healthcare Reimbursement (CAHR) held the Market Access 201 conference in … Read More →

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Updates   The latest update as of June 30, 2017 has been issued by the pan-Canadian … Read More →

Toronto, July 5, 2017 – Arvind Mani and Sherry O’Quinn are pleased to announce our newest strategic partnership with Dominika Dabrowski of DKDA Consulting. Dominika has 12+ years … Read More →

The MORSE KEY: Upcoming Events and Conferences   There a number of conferences and events that individuals in market access may be … Read More →

Topic 1: PMPRB Panel   On Tuesday, June 13, 2017, the Canadian Association for Healthcare Reimbursement (CAHR) held its Market Access 201 … Read More →

Mani & O’Quinn Reimbursement Strategy Experts (MORSE) Consulting Inc. is pleased to introduce MORSE WIRE, a new feature on our website. MORSE … Read More →

Great-West Life introduces the SMART drug plan   In June 2017, Great-West Life is introducing the SMART drug plan, aiming for Sustainable, … Read More →

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Updates   The latest update as of May 31, 2017 has been issued by the pan-Canadian … Read More →

Changes, Updates and Reminders Related to CDR Guidelines   On Friday, June 9th, CADTH issued a CDR Update with a number of … Read More →

INESSS Introduces New Pre-NOC and Biosimilar Guidance   The Institut national d’excellence en santé et en services sociaux (INESSS) released its new … Read More →

The MORSE KEY: Upcoming Events and Conferences There a number of conferences and events that individuals in market access may be interested … Read More →

Consultations Commence for Major Changes to Canadian Pharmaceutical Policy   On May 16, 2017, the Federal Minister of Health, the Hon. Jane … Read More →

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update   The latest update as of April 30, 2017 has been issued by the pan-Canadian … Read More →

Toronto, May 1, 2017 – Arvind Mani and Sherry O’Quinn are pleased to announce a strategic partnership with Brent Korte of Impact Consulting … Read More →

Ontario Update   The Annual Report Card for the Ontario Drug Benefit Program for their 2015/16 fiscal year has been released. The … Read More →

There a number of conferences and events that individuals in market access may be interested in for the upcoming month: Government/Agencies May … Read More →

Ontario Update   The Ontario Drug Benefit (ODB) Formulary / Comparative Drug Index (Formulary) has been updated and becomes effective April 27, … Read More →

DKDA Consulting and MORSE Consulting have created an infographic which provides key tips to planning, preparing, and participating in market access advisory … Read More →

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update   The latest update as of March 31, 2017 has been issued by the pan-Canadian … Read More →

Mani & O’Quinn Reimbursement Strategy Experts (MORSE) Consulting Inc. is pleased to introduce a new feature on our website. The MORSE KEY … Read More →

Dominika Dabrowski (DKDA Consulting), Arvind Mani (MORSE Consulting), and Sherry O’Quinn (MORSE Consulting) have collaborated on an article that describes best practices … Read More →

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update   The pan-Canadian Pharmaceutical Alliance Office (pCPAO) updated the status of negotiations on brand name … Read More →

Health Canada Update   On March 10, 2017, Health Canada issued a guidance document which describes how it discloses confidential business information … Read More →

CAPCA has initiated consultations with stakeholders on its recent initiative aimed at addressing the challenges facing the oncology drug system.   The … Read More →

Pink Sheet Pharma Intelligence published the attached article by Francesca Bruce on February 17, 2017.  The article provides a helpful summary of … Read More →

Health Canada Update   On February 24, 2017, Health Canada issued the Terms of Reference for the Scientific Advisory Panel on Opioid … Read More →

BC Update   The British Columbia Pharmacare newsletter was published on February 27, 2017   See British Columbia’s Newsletter   As noted … Read More →

The pCPA has completed negotiations with 3 manufacturers of drugs used to treat Hepatitis C   The pan-Canadian Pharmaceutical Alliance (pCPA), in … Read More →

Alberta Update   The Alberta Drug Benefit List (DBL) / Alberta Human Services Drug Benefit Supplement has been updated and becomes effective … Read More →

Ontario Update   Ontario Drug Benefit (ODB) Formulary / Comparative Drug Index (Formulary) has been updated and becomes effective February 28, 2017. … Read More →

Quebec’s revised List of Medications has been posted, with Formulary changes effective as of February 15, 2017. For more information and to … Read More →

The Patented Medicine Prices Review Board Provides an Update on its Activities   The Patented Medicine Prices Review Board (PMPRB) released its … Read More →

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update   The pan-Canadian Pharmaceutical Alliance Office (pCPAO) updated the status of negotiations on brand name … Read More →

The pan-Canadian Pharmaceutical Alliance (pCPA) Office released the monthly statistics for pCPA negotiations up to and including December 31, 2016.   To … Read More →

Mani & O’Quinn Reimbursement Strategy Experts (MORSE) launched to help clients develop strategies to optimize reimbursement success.   Toronto, January 26, … Read More →

MORSE Team, Author at MORSE Consulting Inc.
css.php